COMMUNIQUÉS West-GlobeNewswire

Capricor to Host Key Opinion Leader Lunch on March 9

28/02/2018 - 14:00

LOS ANGELES, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ) today announced it will host a Key Opinion Leader Lunch in New York City on March 9 featuring four distinguished speakers to discuss [...]

Poseida Therapeutics Appoints Mark Gergen as Chief Business Officer and Chief Financial Officer

28/02/2018 - 14:00

SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced that [...]

Maple Leaf Provides Further Details on the Transfer of its Listing to the Aequitas NEO Exchange Inc.

28/02/2018 - 14:00

CALGARY, Alberta, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (TSX-V: MGW ) (OTCQB:MGWFF) is pleased to provide further information to the Company’s press release [...]

Aclaris Therapeutics to Webcast Conference Call Discussing Fourth Quarter and Full Year 2017 Financial Results on March 12, 2018

28/02/2018 - 14:00

WAYNE, Pa., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative and [...]

Actinium Pharmaceuticals Highlights Key Activities and Progress at BMT Tandem Meetings, the Combined Annual Meetings of the Two Leading Transplant Organizations

28/02/2018 - 13:30

- Protocol changes to the control arm of the pivotal Phase 3 trial for Iomab-B well received at the Company’s investigator meeting and by Iomab-B’s scientific advisory board - Product theater presentations featuring [...]

Conatus Pharmaceuticals to Report Fourth Quarter and Full Year 2017 Financial Results

28/02/2018 - 13:30

SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq: CNAT ) today announced that it will report financial results for the fourth quarter and full year ended December 31, 2017, after the [...]

Budget 2018: Ovarian cancer research funding still a concern for women

28/02/2018 - 13:30

Toronto, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Advocates pressing for federal investment to address ovarian cancer are today re-iterating the need for specific and targeted investments in ovarian cancer research. While [...]

Budget 2018 : Le financement de la recherche sur le cancer de l’ovaire préoccupe toujours les femmes

28/02/2018 - 13:30

Toronto, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Les porte-parole qui demandaient des investissements fédéraux pour lutter contre le cancer de l’ovaire réitèrent aujourd’hui la nécessité d’investissements spécifiques et [...]

Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day

28/02/2018 - 13:30

SOUTH SAN FRANCISCO, Calif., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK ) today announced that it is joining the global initiative to raise awareness of Rare Disease Day®, an [...]

Strongbridge Biopharma plc to Host Conference Call on March 12, 2018 to Announce Fourth Quarter and Year-End 2017 Financial Results and Provide Corporate Update

28/02/2018 - 13:30

DUBLIN, Ireland and TREVOSE, Pa., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq: SBBP ), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]

Terveystalo Plc: Notice of the Annual General Meeting

28/02/2018 - 13:01

Terveystalo Plc, Stock Exchange Release 28 February 2018 at 2:00 PM EET Notice is given to the shareholders of Terveystalo Plc of the Annual General Meeting to be held on Thursday, 12 April 2018 at 3:00 p.m. at Marina [...]

Midatech receives Orphan Drug Designation for MTD119 from the European Medicines Agency

28/02/2018 - 13:00

28 February 2018 Midatech Pharma PLC ("Midatech" or the "Company") Midatech receives Orphan Drug Designation for MTD119 from the European Medicines Agency Midatech (AIM: MTPH, Nasdaq: MTP), the international specialty [...]

Lexicon Pharmaceuticals Announces Poster Presentation at the 15th Annual ENETS Conference

28/02/2018 - 13:00

THE WOODLANDS, Texas, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), announced today that data from a poster highlighting XERMELO ® (telotristat ethyl) will be presented at the upcoming [...]

Trevena to Host Conference Call on March 7th to Discuss Full Year 2017 Financial Results

28/02/2018 - 13:00

CHESTERBROOK, Pa., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced that it will host a conference call on Wednesday, March 7, 2018 at 8:00 am EST to review financial results as of and for [...]

Melinta Therapeutics To Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018

28/02/2018 - 13:00

NEW HAVEN, Conn., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, [...]

Amicus Therapeutics Announces Full-Year 2017 Financial Results and 2018 Corporate Updates

28/02/2018 - 13:00

Galafold Expansion Continues with 360+ Fabry Patients Treated Today - on Track to Achieve FY18 Revenue Guidance of $75M-$85M Significant Progress Across Pompe Clinical, Regulatory and Manufacturing Activities - [...]

Cesca Therapeutics Inc. to Present at the 8th Spring Meeting of the International Society for BioProcess Technology (ISBiotech)

28/02/2018 - 13:00

RANCHO CORDOVA, Calif., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ: KOOL ) a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today [...]

VitalHub Subsidiary HInext Adds 16 New Customers in New York State

28/02/2018 - 13:00

TORONTO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX-V: VHI ) is pleased to announce that its subsidiary HInext Inc. (“HInext”) has obtained 16 new customers in New York State, [...]

Axsome Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results on March 7, 2018

28/02/2018 - 13:00

NEW YORK, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]